7 analysts have expressed a variety of opinions on Eastman Chemical EMN over the past quarter, offering a diverse set of opinions from bullish to bearish.
The following table summarizes their recent ratings, shedding light on the changing sentiments within the past 30 days and comparing them to the preceding months.
| Bullish | Somewhat Bullish | Indifferent | Somewhat Bearish | Bearish | |
|---|---|---|---|---|---|
| Total Ratings | 3 | 1 | 3 | 0 | 0 |
| Last 30D | 0 | 1 | 0 | 0 | 0 |
| 1M Ago | 0 | 0 | 0 | 0 | 0 |
| 2M Ago | 1 | 0 | 0 | 0 | 0 |
| 3M Ago | 2 | 0 | 3 | 0 | 0 |
Analysts' evaluations of 12-month price targets offer additional insights, showcasing an average target of $100.0, with a high estimate of $121.00 and a low estimate of $89.00. This current average has increased by 5.26% from the previous average price target of $95.00.
Decoding Analyst Ratings: A Detailed Look
The standing of Eastman Chemical among financial experts becomes clear with a thorough analysis of recent analyst actions. The summary below outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.
| Analyst | Analyst Firm | Action Taken | Rating | Current Price Target | Prior Price Target |
|---|---|---|---|---|---|
| Aleksey Yefremov | Keybanc | Raises | Overweight | $121.00 | $101.00 |
| Colin Isaac | Redburn Atlantic | Announces | Buy | $110.00 | - |
| Patrick Cunningham | Citigroup | Lowers | Buy | $95.00 | $96.00 |
| Arun Viswanathan | RBC Capital | Lowers | Sector Perform | $89.00 | $91.00 |
| Vincent Anderson | Stifel | Lowers | Buy | $101.00 | $102.00 |
| Joshua Spector | UBS | Raises | Neutral | $93.00 | $91.00 |
| Joshua Spector | UBS | Raises | Neutral | $91.00 | $89.00 |
Key Insights:
- Action Taken: Responding to changing market dynamics and company performance, analysts update their recommendations. Whether they 'Maintain', 'Raise', or 'Lower' their stance, it signifies their response to recent developments related to Eastman Chemical. This offers insight into analysts' perspectives on the current state of the company.
- Rating: Analyzing trends, analysts offer qualitative evaluations, ranging from 'Outperform' to 'Underperform'. These ratings convey expectations for the relative performance of Eastman Chemical compared to the broader market.
- Price Targets: Analysts explore the dynamics of price targets, providing estimates for the future value of Eastman Chemical's stock. This examination reveals shifts in analysts' expectations over time.
Assessing these analyst evaluations alongside crucial financial indicators can provide a comprehensive overview of Eastman Chemical's market position. Stay informed and make well-judged decisions with the assistance of our Ratings Table.
Stay up to date on Eastman Chemical analyst ratings.
Discovering Eastman Chemical: A Closer Look
Established in 1920 to produce chemicals for Eastman Kodak, Eastman Chemical has grown into a global specialty chemical company with manufacturing sites around the world. The company generates the majority of its sales outside of the United States, with a strong presence in Asian markets. During the past several years, Eastman has sold noncore businesses, choosing to focus on higher-margin specialty product offerings.
Eastman Chemical: Delving into Financials
Market Capitalization Analysis: The company exhibits a lower market capitalization profile, positioning itself below industry averages. This suggests a smaller scale relative to peers.
Negative Revenue Trend: Examining Eastman Chemical's financials over 3 months reveals challenges. As of 31 December, 2023, the company experienced a decline of approximately -7.0% in revenue growth, reflecting a decrease in top-line earnings. As compared to its peers, the revenue growth lags behind its industry peers. The company achieved a growth rate lower than the average among peers in Materials sector.
Net Margin: Eastman Chemical's net margin is impressive, surpassing industry averages. With a net margin of 14.05%, the company demonstrates strong profitability and effective cost management.
Return on Equity (ROE): Eastman Chemical's ROE excels beyond industry benchmarks, reaching 5.74%. This signifies robust financial management and efficient use of shareholder equity capital.
Return on Assets (ROA): Eastman Chemical's ROA stands out, surpassing industry averages. With an impressive ROA of 2.12%, the company demonstrates effective utilization of assets and strong financial performance.
Debt Management: With a below-average debt-to-equity ratio of 0.89, Eastman Chemical adopts a prudent financial strategy, indicating a balanced approach to debt management.
Analyst Ratings: What Are They?
Analysts work in banking and financial systems and typically specialize in reporting for stocks or defined sectors. Analysts may attend company conference calls and meetings, research company financial statements, and communicate with insiders to publish "analyst ratings" for stocks. Analysts typically rate each stock once per quarter.
In addition to their assessments, some analysts extend their insights by offering predictions for key metrics such as earnings, revenue, and growth estimates. This supplementary information provides further guidance for traders. It is crucial to recognize that, despite their specialization, analysts are human and can only provide forecasts based on their beliefs.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
date | ticker | name | Price Target | Upside/Downside | Recommendation | Firm |
|---|
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
